A rapid flow cytometric technique for the detection of platelet-monocyte complexes, activated platelets and platelet-derived microparticles

International Journal of Laboratory Hematology

Volumn 31, Issue 4, 2009, Pages 430-439

  Pearson, Laura ^a,b   Thom, Jim ^a   Adams, Murray ^b   Oostryck, Robert ^b   Krueger, Rom ^a   Yong, Gerald ^a   Baker, Ross ^a,c  

^a ROYAL PERTH HOSPITAL   (Australia)

^b CURTIN UNIVERSITY   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Activated platelets; Flow cytometry; Percutaneous coronary intervention; Platelet monocyte complexes

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; BLOOD CLOTTING FACTOR 10; CD40 LIGAND; CLOPIDOGREL; HEPARIN; PADGEM PROTEIN; PHOSPHOLIPID;

ADULT; ARTICLE; BLOOD SAMPLING; BOLUS INJECTION; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTINUOUS INFUSION; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HEART INFARCTION; HUMAN; HUMAN CELL; MALE; MONOCYTE; PERCUTANEOUS CORONARY INTERVENTION; PHOSPHOLIPID BLOOD LEVEL; PLATELET MICROPARTICLE; PRIORITY JOURNAL; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOSIS; UNSTABLE ANGINA PECTORIS;

ADULT; BLOOD PLATELETS; CD40 LIGAND; COLLAGEN; FEMALE; FLOW CYTOMETRY; HUMANS; MALE; MIDDLE AGED; MONOCYTES; P-SELECTIN; PHOSPHOLIPIDS; PLATELET ACTIVATION; PLATELET COUNT; REPRODUCIBILITY OF RESULTS; THROMBOSIS;

EID: 67651087058     PISSN: 17515521     EISSN: 1751553X     Source Type: Journal    
DOI: 10.1111/j.1751-553X.2008.01059.x     Document Type: Article

References (35)

1. Andre P. (2004) P-selectin in haemostasis. British Journal of Haematology 125, 298 306.
2. Aukrust P., Muller F., Ueland T., Berget T., Aaser E., Brunsvig A., Solum N., Forfang K., Froland S. Gullestad L. (1999) Enhanced levels of soluble and membrane-bound CD40L in patients with unstable angina: possible refelction of T lymphocyte and platelet involvement in the pathogensis of acute coronary syndromes. Circulation 100, 614 620.
3. Barnard M., Krueger L.A., Frelinger A., III., Furman M. Michelson A. (2003) Whole blood analysis of leukocyte-platelet aggregates. In Current Protocols in Cytometry, pp. 6.15.11 6.15.18. John Wiley and Sons.
4. Berg J., Gerristen W., Haas F., Kelder H., Verheugt F. Plokker H. (2002a) High-dose aspirin in addition to daily low-dose aspirin dcreases activation in patients before and after percutaneous coronary intervention. Thrombosis Research 105, 385 390.
5. Berg J., Gerristen W., Haas F., Kelder J., Verheugt F. Plokker H. (2002b) Pretreatment with oral anticoagulanys decreased platelet activaiton before and after percutaneous coronary intervention. Thrombosis and Haemostasis 88, 924 930.
6. Cassar K., Bachoo P., Ford I., Greaves M. Brittenden J. (2003) Platelet activation is increased in peripheral arterial disease. Journal of Vascular Surgery 38, 99 103.
7. Craft J., Masci P., Roberts M., Brighton T., Garrahy P., Cox S. Marsh N. (2004) Increased platelet-derived microparticles in the coronary circulation of percutaneous transluminal coronary angioplasty patients. Blood Coagulation and Fibrinolysis 15, 475 482.
8. Ejim O., Powling M., Dandone P., Kernoff P. Goodall A. (1990) A flow cytometric analysis of fibronectin binding to platelets from patients with peripheral vascular disease. Thrombosis Research 58, 519 524.
9. Exner T., Joseph J., Low J., Connor D. Ma D. (2003) A new activated factor X-based clotting method with improved specificity for procoagulant phospholipid. Blood Coagulation and Fibrinolysis 14, 773 779.
10. Furman M.I., Benoit S.E., Barnard M.R., Valeri C.R., Borbone M.L., Becker R.C., Hechtman H.B. Michelson A.D. (1998) Increased platelet reactivity and circulating monocyte-platelet aggregates in patients with stable coronary artery disease. Journal of American College of Cardiology 31, 352 358.
11. Furman M.I., Barnard M.R., Krueger L.A., Fox M.L., Shilale E.A., Lessard D.M., Marchese P., Frelinger A.L., III., Goldberg R.J. Michelson A.D. (2001a) Circulating monocyte-platelet aggregates are an early marker of acute myocardial infarction. Journal of the American College of Cardiology 38, 1002 1006.
12. Furman M.I., Kereiakes D., Krueger L.A., Mueller M., Pieper K., Broderick T., Schneider J., Howard W., Fox M.L., Barnard M.R., Frelinger A.L., III. Michelson A.D. (2001b) Leukocyte-platelet aggregation, platelet surface P-selectin, and platelet surface glycoprotein IIIa after percutaneous coronary intervention: Effects of dalteparin or unfractionated heparin in combination with abciximab. American Heart Journal 142, 790 798.
13. Hagberg I.A. Lyberg T. (2000) Evaulation of circulating platelet-leukocyte conjugates: a sensitive flow cytometric assay well sutied for clinical studies. Platelets 11, 151 160.
14. Heijnen H.F., Schiel A.E., Fijnheer R., Geuze H.J. Sixma J.J. (1999) Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules. Blood 94, 3791 3799.
15. Hickerson D.H.M. Bode A.P. (2002) Flow cytometry of platelets for clinical analysis. Hematology/Oncology Clinics of North America 16, 421 454.
16. Holme P.A., Brosstad F. Solum N.O. (1995) Platelet-derived microvesicles and activated platelets express factor Xa activity. Blood Coagulation and Fibrinolysis 6, 302 310.
17. Kim H.K., Song K.S., Lee E.S., Lee Y.J., Park Y.S., Lee K.R. Lee S.N. (2002) Optimized flow cyometric assay for the measurement of platelet microparticles in plasma: pre-analytic and analytic considerations. Blood Coagulation and Fibrinolysis 13, 393 397.
18. Li N., Goodall A.H. Hjemdahl P. (1997) A sensitive flow cytometric assay for circulating platelet-leucocyte aggregates. British Journal of Haematology 99, 808 816.
19. Linden M.D., Frelinger A.L., III., Barnard M.R., Przyklenk K., Furman M.I. Michelson A.D. (2004) Application of flow cytometry to platelet disorders. Seminars in Thrombosis and Hemostasis 30, 501 511.
20. Mascelli M.A., Lance E.T., Damaraju L., Wagner C.L., Weisman H.F. Jordan R.E. (1998) Pharmacodynamic profile of short-term Abciximab treatment demonstrates prolonged platelet inhibition with gradual recovery from GP IIb/IIIa receptor blockade. Circulation 97, 1680 1688.
21. McCabe D.J.H., Harrison P., Mackie I.J., Sidhu P.S., Purdy G., Lawrie A.S., Watt H., Brown M.M. Machin S.J. (2004) Platelet degranulation and monocyte-platelet complex formation are increased in the acute and convalescent phases after ischaemic stroke or transient ischaemic attack. British Journal of Haematology 125, 777 787.
22. Michelson A., Barnard M., Krueger L.A., Valeri C. Furman M. (2001) Circulating monocyte-platelet aggregates are a more sensitive marker of in vivo platelet activation than platelet surface P-selectin: studies in baboons, human coronary intervention and human acute myocardial infarction. Circulation 104, 1533 1537.
23. Mody M., Lazarus A.H., Semple J.W. Freedman J. (1999) Preanalytical requirements for flow cytometric evaluation of platelet activation: choice of anticoagulant. Transfusion Medicine 9, 147 154.
24. Morel O., Hugel B., Jesel L., Mallat Z., Lanza F., Douchet M., Zupan M., Chauivn M., Cazenave J., Tedgui A., Freyssinet J. Toti F. (2004) Circulating procoagulant microparticles and soluble GPV in myocaridal infarction treated by primary percutaneous transluminal coronary angioplasty. A possible role for GPIIb-IIIa antagonists. Journal of Thrombosis and Haemostasis 2, 1118 11126.
25. Nannizzi-Alaimo L., Rubenstein M.H., Alves V.L., Leong G.Y., Phillips D.R. Gold H.K. (2002) Cardiopulmonary bypass induces release of soluble CD40 Ligand. Circulation 105, 2849 2854.
26. Nomura S., Masahiko S., Katsura K., Xie G.L., Miyazaki Y., Miyake T., Kido H., Kagawa H. Fukuhara S. (1995) Platelet-derived microparticles may influence the development of atherosclerosis in diabetes mellitus. Atherosclerosis 116, 235 240.
27. Quinn M., Bhatt D., Zidar F., Vivekananthan D., Chew D., Ellis S., Plow E. Topol E. (2004) Effect of clopidogrel pretreatment on inflammatory marker expression in patients undergoing percutaneous coronary intervention. American Journal of Cardiology 93, 679 684. (Pubitemid 38338553)
28. Ray M., Walters J., Cameron B., Wood P. Aroney C. (2005) Platelet-monocyte aggregates predict troponin rise after percutaneous coronary intervention and are inhibited by Abciximab. Internation Journal of Cardiology 101, 249 255.
29. Schmitz G., Rothe G., Ruf A., Barlage S., Tschoepe D., Clementson K.J., Goodall A.H., Michelson A.D., Nurden A.T. Shankey T.V. (1998) European working group on clinical cell analysis: consensus protocol for the flow cytometric characterisation of platelet function. Thrombosis and Haemostasis 79, 885 896.
30. Shattil S.J., Cunningham M. Hoxie J.A. (1987) Detection of activated platelets in whole blood using activation-dependent monoclonal antibodies and flow cytometry. Blood 70, 307 315.
31. Prasad K., Andre P., Yan Y. Phillips D.R. (2003) The platelet CD40L/GP IIb-IIIa axis in atherothrombotic disease. Current Opinion in Hematology 10, 356 361.
32. Thom J., Gilmore G., Yi Q., Hankey G.J. Eikelboom J. (2004) Measurement of soluble P-selectin and soluble CD40 ligand in serum and plasma. Journal of Thrombosis and Haemostasis 2, 1 2.
33. Vidal C., Spaulding C., Picard F., Schaison F., Melle J., Weber S. Fontenay-Roupie M. (2001) Flow cytometry detection of platelet procoagulant activity and microparticles in patients with unstable angina treated by percutaneous coronary angiplasty and stent implantation. Thrombosis and Haemostasis 86, 784 790.
34. Wehmeier A., Tschope D., Esser J., Menzel C., Nieuwenhuis H.K. Schneider W. (1991) Circulating activated platelets in myeloproliferative disorders. Thrombosis Research 61, 271 278.
35. Zeller J.A., Tschoepe D. Kessler C. (1999) Circulating platelets show increased activation in patients with acute cerebral ischemia. Thrombosis and Haemostasis 81, 373 377.